Form D · Biotechnology
PROTALEX INC
Florham Park, NJ · CIK 0001099215
Offering snapshot reported Mar 9, 2018 · SEC filing
- Reported sold
- $1.43M Offering amount: $2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 28, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2018 | Initial | $1,425,000 | No comparison | 8 | SEC filing |
| Jan 23, 2014 | Initial | $2,828,000 | No comparison | 23 | SEC filing |
| Nov 19, 2009 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Jun 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-307379
Senior Convertible Note, convertible into shares of common stock at a price of $0.20 per share.
Source: Form D, filed Mar 9, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marco M Elser | Director |
| Arnold P Kling | Director, Executive |
| Kirk M Warshaw | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
131 Columbia Turnpike Suite 1
Florham Park, NJ, 07932
Florham Park, NJ, 07932